David M. Dilts, Ph.D., M.B.A.
- click here
Dr. Dilts is Director of Clinical Research for the OHSU Knight Cancer Institute and Professor of Healthcare Management at the Oregon Health & Science University. His academic career has been broad, spanning being a professor of: accounting, engineering, management, management of technology, management science, and optometry at various times. Prior to coming to the Knight, he held a unique joint professorship between the Owen Graduate School of Management and the Vanderbilt University School of Engineering, where he was the founding Director of Engineering Management Program and co-director of the Center for Management Research in Healthcare (cMHRc.org). This center, supported by the National Cancer Institute (NCI), WebMD, and others, has as its mission the exchange of knowledge between the management research and healthcare to dramatically impact practice of medicine. One research stream, funded by the NCI, applied management principles to significantly reduce the time and steps required to open oncology clinical trials. Another research stream is addressing long standing issues in clinical research, including low accruals to clinical trials, geographic equipoise of clinical research, and strategic focus in oncology research.His work has been published in over 160 articles, conference papers and presentations, book chapters, books and monographs, including Clin Cancer Res, J Clin Oncology, Medical Decision Making, J of Med Info Assoc, Management Accounting, J of Tech Transfer, IEEE Trans on Systems, Man & Cybernetics, and J of Supply Chain Management. He has published on range of topics, from complexity in supply chain networks, to delays in opening oncology clinical trials and to issues with business incubation.
"Time has come to raise the bar in oncology clinical trials,"
"A "Three-Plus-One" Evaluation Model for Clinical Research Management,"
"Building expertise in translational processes through partnerships with schools of business,"
"Characteristics of oncology clinical trials: Insights from a systematic analysis of clinicaltrials.gov,"
"Estimating Return on Investment in Translational Research: Methods and Protocols,"